Cargando…

OR06-05 Inadequate High Mitochondrial ATP-Synthesis Explains “Non-Fatty-Liver” in Patients with Acromegaly

Background Patients with active acromegaly exhibit low hepatocellular lipid content (HCL) despite pronounced insulin resistance. This contrasts the strong association of insulin resistance with non-alcoholic fatty liver disease in the general population. Acromegaly may therefore help to elucidate an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fellinger, Paul, Wolf, Peter, Pfleger, Lorenz, Martin, Krssak, Kristaps, Klavins, Stefan, Wolfsberger, Alexander, Micko, Patricia, Carey, Bettina, Gürtl, Vila, Greisa, Raber, Wolfgang, Clemens, Fürnsinn, Scherer, Thomas, Siegfried, Trattnig, Kautzky-Willer, Alexandra, Krebs, Michael, Yvonne, Winhofer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209759/ http://dx.doi.org/10.1210/jendso/bvaa046.1859

Ejemplares similares

SAT-431 Parameters of Glucose Metabolism Independently Predict Post Glucose Load Growth Hormone Concentrations in Patients with Acromegaly
por: Micko, Alexander, et al.
Publicado: (2019)

LBMON175 Nadir Growth Hormone Concentrations In Patients With Acromegaly Relate To Disease Activity, Glucose Metabolism, BMI And Sex
por: Schernthaner-Reiter, Marie Helene, et al.
Publicado: (2022)

MON-318 Acute, Life-Threatening and Perioperative Complications in Cushing’s Syndrome: Predictors and Outcomes
por: Schernthaner-Reiter, Marie Helene, et al.
Publicado: (2020)

Long-Term Corticotroph Function Following Cure of Cushing’s Syndrome
por: Schernthaner-Reiter, Marie Helene, et al.
Publicado: (2021)

OR23-06 Is the Improved Glucose Homeostasis in Patients with Acromegaly Treated with Pegvisomant Caused by Improved Glucagon Secretion?
por: Jørgensen, miss, Nanna Thurmann, et al.
Publicado: (2020)

Addition of Cabergoline to Oral Octreotide Capsules May Improve Biochemical Control in Patients With Acromegaly Who Are Inadequately Controlled With Monotherapy
por: Fleseriu, Maria, et al.
Publicado: (2021)

MON-306 Acromegaly Comorbidity Costs, Quality of Life, and Mortality: Lifetime Comparisons for Controlled Acromegaly, Uncontrolled Acromegaly, and the General US Population
por: Whittington, Melanie D, et al.
Publicado: (2020)

ODP320 Immune Organs Enlarged in Acromegaly: Evaluation of Thymus Volume in Patients with Acromegaly
por: Nahit Sendur, Suleyman, et al.
Publicado: (2022)

The Pharmacological Burden of Comorbidities in Acromegaly
por: Fleseriu, Maria, et al.
Publicado: (2021)

SAT-451 Acromegaly and Thyroid Cancer
por: Danilowicz, Karina, et al.
Publicado: (2019)

SAT-257 Coexisting Craniopharyngioma and Acromegaly
por: Yang, Almira, et al.
Publicado: (2020)

Pleurihormonal Pituitary Adenomas Presenting as Acromegaly
por: Schwehr, Megan, et al.
Publicado: (2021)

The Secret Behind Anemia in Patients With Acromegaly
por: Firlatan, Busra, et al.
Publicado: (2021)

THU025 Acromegaly And Central Hyperthyroidism
por: Akhtar, Ahmad, et al.
Publicado: (2023)

THU060 Time To First Remission, Medical Therapy And Survival In Acromegaly: UK Acromegaly Register (UKAR) Study
por: Deshmukh, Harshal, et al.
Publicado: (2023)

Use of Oral Concomitant Medications in Patients With Acromegaly
por: Petersenn, Stephan, et al.
Publicado: (2021)

ODP314 Gynecomastia as the Initial Presentation of Acromegaly.
por: Lim, Frederick, et al.
Publicado: (2022)

ODP306 Diplopia as Presenting Manifestation of Acromegaly
por: Rjoob, Hani, et al.
Publicado: (2022)

FRI356 SIADH In Acromegaly And Cerebrovascular Accident
por: Simrampreet, Gill, et al.
Publicado: (2023)

OR06-06 Pituitary Tumors and Immortalized Cell Lines Generated by Cre-Inducible Expression of SV40 T-Antigen
por: Mortensen, Amanda Helen, et al.
Publicado: (2020)

MON-302 The Prevalence of Acromegaly in the Sleep Apnoea Clinic
por: Lynch, Julie Marie, et al.
Publicado: (2020)

SAT-267 Pregnancy in Acromegaly: Report of Five Cases
por: Burcea, Iulia Florentina, et al.
Publicado: (2020)

Pachydermoperiostosis: A Rare Masquerader of Acromegaly and Thyroid Acropachy
por: Alkaissi, Hussam R, et al.
Publicado: (2021)

THU022 A Case Of Delayed Diagnosis Of Acromegaly
por: Blanchard, Kayla, et al.
Publicado: (2023)

SAT-LB60 Discordant Biological Parameters of Remission in Acromegaly Do Not Increase the Risk of Hypertension or Diabetes: A Study With the Liege Acromegaly Survey Database
por: Amodru, Vincent, et al.
Publicado: (2020)

SAT-249 Polyarticular Osteoarthritis: A Disabling Manifestation of Acromegaly
por: Khan, Azkia, et al.
Publicado: (2020)

MON-LB52 Evaluation of Arterial Stiffness in Acromegaly Patients
por: alagüney, sevil, et al.
Publicado: (2020)

MON-310 Factors Associated with Remission After Surgery for Acromegaly
por: Cunha, Clara, et al.
Publicado: (2020)

SAT-251 New Diagnosis of Acromegaly with DKA as Initial Presentation
por: Gundluru, Rajani, et al.
Publicado: (2020)

Clinical Presentation and Management of Patients With Acromegaly at a University Hospital
por: Leao, Felipe A, et al.
Publicado: (2021)

The Change of Bone Turnover Markers and Bone Remodelling Balance in Acromegaly
por: Chen, Huan, et al.
Publicado: (2021)

THU065 Evaluation Of Sarcopenia And Bone Health In Patients With Acromegaly
por: Eroglu, Imdat, et al.
Publicado: (2023)

OR06-01 The Role of Germline Defects in Cushing’s Disease
por: Hernández-Ramírez, Laura C, et al.
Publicado: (2020)

SAT-473 Acromegaly and Drug-Induced Parkinsonism Were Controlled by Lanreotide
por: Iwabuchi, Masayasu
Publicado: (2019)

OR32-2 Alpha Klotho as a Marker of Disease Activity in Acromegaly
por: Schweizer, Junia, et al.
Publicado: (2019)

SAT-LB48 Novel Genetic Variant of Carney Complex With Acromegaly
por: Cristiano, Elizabeth, et al.
Publicado: (2020)

MON-298 IGF-1 in the Early Post-operative Assessment of Acromegaly
por: Donegan, Diane, et al.
Publicado: (2020)

Changes in Quality of Life After Long-Term Biochemical Control of Acromegaly
por: Kimball, Allison, et al.
Publicado: (2021)

ODP319 IGF-1 and BMI are Associated in Obese Patients with Acromegaly
por: Khiyami, Anamil, et al.
Publicado: (2022)

SAT-471 Abnormal Thyroid Function Tests in Acromegaly: A Clinical Conundrum
por: Fernandes, Stuti, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_096ejn2b27or4scf006sa0jjnv